A new study strengthens the view that SARS-CoV-2:
disrupts brain homeostasis,
alters ionic & neurotransmitter balance,
and triggers lasting epigenetic reprogramming.
Researchers exposed human primary astrocytes to Delta and Omicron.
The results are striking🧵
Astrocytes were infected with Delta and Omicron at a very low viral load (MOI 0.2).
After just 6 hours, RNA-seq revealed major transcriptional shifts
Omicron deregulated 346 genes (197 ↑, 149 ↓)
Delta deregulated 341 (215 ↑, 126 ↓)
About half of the changes overlapped.
Even minimal exposure triggered broad molecular changes within hours.
Viral sensing and immune response.
Astrocytes primarily activated TLR2, but not RIG-I or NLRP3 - meaning they sensed the virus without launching a full antiviral storm.
Only 16 genes involved in interferon and interleukin signaling were affected.
This represents a low-grade immune activation, not an acute inflammation. It’s exactly the kind of chronic, silent neuroinflammation seen in long COVID.
Neurotransmitters - the brain’s language disrupted.
The infection rewired how astrocytes handle major neurotransmitters:
Glutamate
↓ EAAT1 (SLC1A3) & EAAT2 (SLC1A2) - impaired glutamate uptake - excitotoxicity risk.
↑ mGluR5 (GRM5) - linked to anxiety, depression, and suicidal behavior.
Too much glutamate = neuronal overactivation, sleep disruption, cognitive overload.
GABA
↓ GABRB2, ↑ GABRG3 - loss of inhibitory control.
The brain loses its brake.
Purinergic (ATP) signaling
↓ P2RY1, P2RY6, P2RY11; ↑ ENTPD2 - disrupted energy & sleep regulation.
The brain’s timekeeping and energy balance start to fall apart.
Neurotrophic factors - a protective overreaction.
Astrocytes increased BDNF, NT-4, GDNF, and TrkC (NTRK3) - an attempt to protect and remodel neurons.
But over time, this may lead to maladaptive rewiring rather than repair.
Meanwhile, NRTN (a motor neuron protector) dropped - reducing resilience.
The BBB - the vascular barrier also shifted.
↑ EDN1 (endothelin-1) - promotes vascular permeability.
Tight junction proteins changed unevenly - CLDN16 rose, but CLDN3, 7, 15 fell.
The BBB doesn’t simply open - it becomes patchy and unstable, allowing microscopic leaks and immune infiltration.
Non-coding RNAs - the epigenetic fingerprint.
Astrocytes dramatically altered regulatory RNAs
↓ BDNF-AS - transient rise in BDNF, but disrupted long-term control.
↓ MALAT1 & NEAT1 (especially in Omicron sic) - loss of neuroprotective tone, weaker BBB integrity.
These are epigenetic changes - durable shifts in how the cell reads its genome.
They may underlie the persistent cognitive and neurological symptoms of long COVID.
Delta vs Omicron - two paths, same destination
Delta acted more aggressively, with stronger cytokine signaling and deeper glutamate imbalance.
Omicron was quieter, but it rewired regulatory layers - especially noncoding RNAs like MALAT1 and NEAT1.
In short.
Delta burns fast (acute dysfunction),
Omicron programs slow (lasting dysregulation).
Both impair astrocyte health - and with it, the brain’s ability to keep itself in balance.
Sum:
SARS-CoV-2 reprograms the brain - quietly but deeply.
Disrupting homeostasis
Distorting neurotransmission
Rewriting epigenetic control
These are measurable, biological changes - not psychological aftereffects.
And they appear within hours of exposure.
Bhide et al., Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants Delta and Omicron in human astrocytes. nature.com/articles/s4159…
What emerges here are striking parallels to viruses known for long-term neuroimmune interference - HIV, EBV, CMV.
All manipulate host gene expression, silence antiviral responses, and reshape glial signaling to secure persistence within the nervous system.
SARS-CoV-2 now shows the same pattern:
low-grade inflammation, altered cytokine balance, disruption of neurotransmitter circuits, and epigenetic reprogramming of astrocytes.
The difference is scale and timing -
what those viruses evolved over millennia to sustain chronically, SARS-CoV-2 is already beginning to reproduce through its post-acute effects.
It doesn’t just set the stage for chronicity.
It’s demonstrating it, biologically and clinically.
It doesn’t merely trigger inflammation.
It shows a long-term shift toward neuroimmune exhaustion.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new preprint from Aarhus University shows something striking:
people with post-COVID, MCS, and functional disorders all share the same brain pattern -
split hemispheres, weakened bridges between left and right (!),
overloaded smell and sensory circuits🧵
The study scanned 57 women (post-COVID, MCS, FSD, controls) using diffusion MRI (DTI).
It didn’t measure brain activity, but rather its wiring - the white-matter highways that carry information between regions.
Result.
Interhemispheric connectivity - the bridge between left and right hemispheres - was reduced by 70% in all three patient groups.
That means information flow across the brain is slower, less coordinated, and less efficient.
Even though Omicron often causes milder illness, it leaves a clear metabolic footprint disrupting liver, immune, and energy metabolism.
A new study shows that even 2-4 weeks after recovery, the body does not return to normal metabolic state🧵
Researchers analyzed blood serum from 300 Omicron patients, 200 recovered, and 380 healthy controls.
Using LC-MS metabolomics, they tracked hundreds of molecules revealing how the infection affects the liver, mitochondria, and immune system.
Over 100 metabolites were significantly altered during infection - that’s expected in any acute illness.
What’s not expected?
Most of these changes did not return to normal even after clinical recovery.
For the first time ever, a human body was instructed to make lab-designed antibodies against SARS-CoV-2 - by itself - from synthetic DNA.
One shot.
No virus.
Protection lasting over a year.🧵
A new Nature Medicine study tested something called DNA-encoded monoclonal antibodies (DMAbs).
Instead of injecting ready made antibodies, scientists injected synthetic DNA that tells your cells how to make them.
Your muscle becomes a mini factory for antibodies.
The DNA carried blueprints for tixagevimab and cilgavimab - the antibodies used in Evusheld.
It was delivered intramuscularly, with short electric pulses (electroporation) that help DNA enter cells.
SARS-CoV-2 is not just a respiratory virus. It acts more like an epigenetic manipulator - a virus that rewires how our genes are read and expressed. A new study shows how the virus edits the body’s epigenetic code🧵
Instead of simply damaging cells, it reprograms the host’s immune system, changing the molecular instructions that guide how the body responds to infection.
This is why COVID-19 can leave such a deep biological footprint. The virus doesn’t have to remain active to keep affecting you - it can alter the settings of your immune and metabolic genes in ways that persist long after recovery.
Smell loss after COVID isn’t just a sensory symptom.
It’s a window into how the virus reshapes the emotional brain.
New imaging data reveal microstructural changes in the amygdala - linking smell, mood, and neuroplastic stress🧵
A new MRI study found structural changes in the amygdala - the brain’s emotional hub - in people with long term smell loss after COVID-19.
This goes far beyond the nose.
Loss of smell after COVID isn’t just damage to nasal cells.
In some people it persists for months or years - and the brain adapts.
Researchers used diffusion tensor MRI (DTI) to examine microstructural white-matter changes in key olfactory–emotional regions.
A possible new diagnostic approach to Long COVID.
Long COVID may involve microcirculatory blockages - tiny, persistent clots known as fibrinaloid microclots.
These abnormal fibrin structures resist breakdown and can obstruct blood flow in the smallest vessels.🧵
The result - local hypoxia, fatigue, muscle weakness, brain fog - classic long COVID symptoms.
Even a slight obstruction means tissues aren’t getting enough oxygen.
A new preprint study by Kell & Pretorius proposes a non-invasive diagnostic tool -
thermal imaging (IR thermography) - using skin temperature patterns to visualize microcirculatory dysfunction.